Short halt in vaping modifies cardiorespiratory parameters and urine metabolome: a randomized trial.


Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 02 2020
Historique:
pubmed: 14 11 2019
medline: 13 5 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

Propylene glycol and glycerol are e-cigarette constituents that facilitate liquid vaporization and nicotine transport. As these small hydrophilic molecules quickly cross the lung epithelium, we hypothesized that short-term cessation of vaping in regular users would completely clear aerosol deposit from the lungs and reverse vaping-induced cardiorespiratory toxicity. We aimed to assess the acute effects of vaping and their reversibility on biological/clinical cardiorespiratory parameters [serum/urine pneumoproteins, hemodynamic parameters, lung-function test and diffusing capacities, transcutaneous gas tensions (primary outcome), and skin microcirculatory blood flow]. Regular e-cigarette users were enrolled in this randomized, investigator-blinded, three-period crossover study. The periods consisted of nicotine-vaping (nicotine-session), nicotine-free vaping (nicotine-free-session), and complete cessation of vaping (stop-session), all maintained for 5 days before the session began. Multiparametric metabolomic analyses were used to verify subjects' protocol compliance. Biological/clinical cardiorespiratory parameters were assessed at the beginning of each session (baseline) and after acute vaping exposure. Compared with the nicotine- and nicotine-free-sessions, a specific metabolomic signature characterized the stop-session. Baseline serum club cell protein-16 was higher during the stop-session than the other sessions (

Identifiants

pubmed: 31721596
doi: 10.1152/ajplung.00268.2019
pmc: PMC7052663
doi:

Substances chimiques

Biomarkers 0
Hemoglobins 0
Nicotine 6M3C89ZY6R
Oxygen S88TT14065

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

L331-L344

Références

Int J Chron Obstruct Pulmon Dis. 2014 Oct 21;9:1225-33
pubmed: 25364242
PLoS One. 2015 Jan 30;10(1):e0116159
pubmed: 25635997
Nat Commun. 2015 Jul 09;6:7726
pubmed: 26158509
Front Physiol. 2018 Mar 06;9:160
pubmed: 29559919
Lancet Respir Med. 2013 Dec;1(10):779-85
pubmed: 24461757
Crit Care. 2015 Jul 16;19:272
pubmed: 26179876
Obesity (Silver Spring). 2016 Sep;24(9):1834-41
pubmed: 27569117
J Anesth. 2006;20(4):331-4
pubmed: 17072703
Front Physiol. 2017 Dec 11;8:1023
pubmed: 29321743
Addict Behav. 2016 Jan;52:91-7
pubmed: 26406973
Br J Clin Pharmacol. 1985 Feb;19(2):239-47
pubmed: 3986082
J Proteome Res. 2017 Oct 6;16(10):3491-3503
pubmed: 28849940
Am J Respir Crit Care Med. 2004 Aug 15;170(4):383-7
pubmed: 15142869
N Engl J Med. 1996 Sep 26;335(13):931-7
pubmed: 8782500
Am J Clin Nutr. 2004 Oct;80(4):932-5
pubmed: 15447901
J Proteome Res. 2010 Dec 3;9(12):6647-54
pubmed: 20853909
Blood Press Monit. 2003 Feb;8(1):27-30
pubmed: 12604933
Chest. 2008 May;133(5):1149-54
pubmed: 18263682
J Am Heart Assoc. 2019 Jan 8;8(1):e010606
pubmed: 30606084
Respir Care. 2012 Nov;57(11):1955-62
pubmed: 23107301
Pediatr Pulmonol. 2012 Apr;47(4):358-66
pubmed: 21901861
Am J Respir Crit Care Med. 1999 Feb;159(2):646-78
pubmed: 9927386
Thorax. 2013 Aug;68(8):752-9
pubmed: 23604381
J Occup Environ Med. 2014 Feb;56(2):149-54
pubmed: 24451609
Pharmacotherapy. 1981 Sep-Oct;1(2):147-60
pubmed: 6927604
Br J Clin Pharmacol. 2003 Dec;56(6):588-99
pubmed: 14616418
Crit Rev Toxicol. 2013 Apr;43(4):363-90
pubmed: 23656560
Am J Respir Crit Care Med. 2018 Jul 1;198(1):123-126
pubmed: 29451806
Oncotarget. 2017 Jul 25;8(30):49915-49930
pubmed: 28611296
Int J Hyg Environ Health. 2019 Jan;222(1):136-146
pubmed: 30220464
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
N Engl J Med. 2019 Aug 22;381(8):705-715
pubmed: 31433918
Respir Res. 2017 Nov 17;18(1):193
pubmed: 29149889
Eur Respir J. 2014 Oct;44(4):1023-41
pubmed: 25063240
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L705-L719
pubmed: 30724099
Chest. 2014 May;145(5):1006-1015
pubmed: 24522562
Chem Res Toxicol. 2017 Oct 16;30(10):1791-1793
pubmed: 28937746
J Proteome Res. 2011 Jan 7;10(1):221-30
pubmed: 21058631
J Appl Physiol (1985). 2018 Jul 1;125(1):117-123
pubmed: 29369741
Front Physiol. 2018 Jul 09;9:853
pubmed: 30038580
Toxicol Mech Methods. 2016 Jul;26(6):389-413
pubmed: 27117495
J Appl Toxicol. 2007 Jan-Feb;27(1):60-6
pubmed: 17186574
OMICS. 2012 Nov;16(11):612-20
pubmed: 23095112
Food Chem Toxicol. 2017 Nov;109(Pt 1):315-332
pubmed: 28882640
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Microcirculation. 2015 May;22(4):276-84
pubmed: 25703861
Inhal Toxicol. 2018 Mar - Apr;30(4-5):159-168
pubmed: 29932004
Sci Rep. 2018 Jul 10;8(1):10378
pubmed: 29991814
Chem Res Toxicol. 2019 Feb 18;32(2):312-317
pubmed: 30656934
Am J Public Health. 1988 Jun;78(6):696-8
pubmed: 3369603
Tob Regul Sci. 2018 Sep;4(5):41-49
pubmed: 30778393
Nicotine Tob Res. 2019 Feb 18;21(3):314-322
pubmed: 30265341
J Am Coll Cardiol. 2007 Aug 28;50(9):823-30
pubmed: 17719466
Chest. 2000 Sep;118(3):656-64
pubmed: 10988186
Lancet Respir Med. 2015 Aug;3(8):613-20
pubmed: 26159408
Inhal Toxicol. 2015;27(9):405-31
pubmed: 26295358
Clin Pharmacol Ther. 1988 May;43(5):488-91
pubmed: 3365914
Int J Environ Res Public Health. 2019 Feb 28;16(5):
pubmed: 30823395
Int J Mol Sci. 2016 Apr 26;17(5):
pubmed: 27128899
Clin Biochem. 2016 Jan;49(1-2):132-8
pubmed: 26385496
Hum Mol Genet. 2013 Dec 1;22(23):4726-38
pubmed: 23842454
J Appl Physiol (1985). 2008 Nov;105(5):1477-85
pubmed: 18756011
Addiction. 2018 Oct;113(10):1874-1882
pubmed: 29882257
Handb Exp Pharmacol. 2009;(192):29-60
pubmed: 19184645

Auteurs

Martin Chaumont (M)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Institute for Translational Research in Cardiovascular and Respiratory Sciences, Université Libre de Bruxelles, Brussels, Belgium.

Vanessa Tagliatti (V)

Department of Human Biology and Toxicology, University of Mons, Mons, Belgium.

El Mehdi Channan (EM)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Institute for Translational Research in Cardiovascular and Respiratory Sciences, Université Libre de Bruxelles, Brussels, Belgium.

Jean-Marie Colet (JM)

Department of Human Biology and Toxicology, University of Mons, Mons, Belgium.

Alfred Bernard (A)

Laboratory of Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.

Sofia Morra (S)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Institute for Translational Research in Cardiovascular and Respiratory Sciences, Université Libre de Bruxelles, Brussels, Belgium.

Guillaume Deprez (G)

Department of Clinical Chemistry, Université Libre de Bruxelles, Brussels, Belgium.

Alain Van Muylem (A)

Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Nadia Debbas (N)

Department of Cardiology, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.

Thomas Schaefer (T)

Cardio-Pulmonary Exercise Laboratory, Université Libre de Bruxelles, Brussels, Belgium.

Vitalie Faoro (V)

Cardio-Pulmonary Exercise Laboratory, Université Libre de Bruxelles, Brussels, Belgium.

Philippe van de Borne (P)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Institute for Translational Research in Cardiovascular and Respiratory Sciences, Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH